세계의 발 및 발목 디바이스 시장 : 디바이스 유형, 용도, 최종사용자, 지역별(-2035년)

Global Foot and Ankle Device Market Research Report Information by Device Type [Orthopedic Implants and Devices (Fixation Devices, Joint Implants), Soft-Tissue Management Devices (Artificial Tendons & Ligaments, Musculoskeletal Reinforcement Devices), Prostheses (Solid Ankle Cushion Heel (SACH) Foot, Single-Axial Prostheses, Multiaxial Prostheses, Dynamic Response/Energy Storing Prostheses, Microprocessor Controlled (Mpc) Prostheses), Bracing and Support Devices], by Application (Trauma, Diabetes, Neurological Disorders, Midfoot Arthrodesis, Deformity Correction, Others), by End User (Hospitals & Clinics, Physiotherapy Centers, Academic & Research Organizations), and by Region (North America, Europe, Asia-Pacific, South America, MEA) Forecast till 2035

Industry Overview

By 2035, the Foot and Ankle Device Market is expected to attain a value of USD 12,680.65 million, registering a steady CAGR of 7.32% during the forecast period. Foot and ankle devices are specialized medical tools or implants used to repair, stabilize, or enhance the function of the foot and ankle. They help in treating injuries, deformities, or degenerative conditions, improving overall movement and comfort.

The global Foot and Ankle Device Market is considerably fueled by the rise in awareness and improved patient awareness in relation to foot and ankle health. As people learn more about early treatment and prevention, they are turning to better devices for recovery and mobility. The rise of digital health literacy and expert advice has led to the adoption of orthopedic products such as braces and custom orthotics, leading to steady growth throughout the global market.

Major Company Development

Major Company Development The most recent developments of Orthofix Medical Inc. indicate an ongoing improvement in orthopedic solutions. In September, 2023, the Company launched its Galaxy Fixation Gemini system in the US. In September 2021 the Company launched its Opus Mg Set for orthopedic use. In March 2020 Orthofix also expanded its facilities by acquiring the FITBONE assets which widened the scope of its femur and tibia limb lengthening treatment.

Key Players

Major players in the global foot and ankle device market are Stryker, Smith+Nephew, Globus Medical, Inc., CONMED Corporation, Johnson & Johnson Inc., Zimmer Biomet, Acumed LLC, Orthox Medical Inc., Arthrex, Inc., and Invibio Ltd.

Report Attribute Details

• Market Size 2024: USD 5,885.75 Million
• Market Size 2035: USD 12,680.65 Million
• CAGR (2025-2035): 7.32%
• Base Year: 2024
• Market Forecast Period: 2025-2035

Industry Segmentations

• By Device Type: Orthopedic Implants and Devices - 7.54%, Soft-Tissue Management Devices - 11.61%.
• By Application: Trauma - 7.65%, Diabetes - 9.85%.
• By End User: Hospitals & Clinics - 7.31%, Physiotherapy Centers - 8.81%.

Regional Analysis

The North American Foot and Ankle Device Market in 2024 was worth USD 2,863.47 million and is expected to enjoy a CAGR of 6.54% over the coming years. The North American Foot and Ankle Device Market enjoys an excellent base of good medical device manufacturers and a highly aware patient base.

The Foot and Ankle Device Market in Europe was worth USD 1,520.90 million in 2024 and is expected to grow at a CAGR of 7.42% over the expected period. Favorable reimbursement policies and good research input from healthcare facilities continue to encourage innovation in the regional market.

The Asia-Pacific area is valued at USD 1,111.63 million in 2024 and is expected to show the fastest growth with a CAGR of 9.37%. Rising healthcare investments, expanding medical tourism, and growing awareness of orthopedic health are key growth enablers.

Latin America's Foot and Ankle Device Market was valued at USD 211.31 million in 2024 and is expected to grow at a CAGR of 5.54%. The region's progress is largely attributed to the improving healthcare ecosystem and increased focus on orthopedic research. Brazil and Mexico dominate the market with strong import channels and expanding hospital networks.

The Middle East and Africa region recorded a market size of USD 178.44 million in 2024, with growth expected at a CAGR of 6.07%. The GCC countries are leading the demand due to rising healthcare spending and investments in orthopedic centers. South Africa's market is steadily evolving with greater awareness of foot care and rehabilitation.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

• 3.1 OVERVIEW
• 3.2 DATA FLOW
  • 3.2.1 DATA MINING PROCESS
• 3.3 PURCHASED DATABASE:
• 3.4 SECONDARY SOURCES:
  • 3.4.1 SECONDARY RESEARCH DATA FLOW:
• 3.5 PRIMARY RESEARCH:
  • 3.5.1 PRIMARY RESEARCH DATA FLOW:
  • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
  • 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
• 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
  • 3.6.1 REVENUE ANALYSIS APPROACH
• 3.7 DATA FORECASTING
  • 3.7.1 DATA FORECASTING TYPE
• 3.8 DATA MODELING
  • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
  • 3.8.2 DATA MODELING:
• 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

• 4.1 INTRODUCTION
• 4.2 DRIVERS
  • 4.2.1 INCREASING INCIDENCE OF SPORTS-RELATED INJURIES
  • 4.2.2 RISING AWARENESS AND PATIENT EDUCATION
  • 4.2.3 RESEARCH AND INNOVATION
• 4.3 RESTRAINTS
  • 4.3.1 STRINGENT REGULATORY REQUIREMENTS
  • 4.3.2 VOLUNTARY PRODUCT RECALL BY MARKET PLAYERS
• 4.4 OPPORTUNITY
  • 4.4.1 GROWING GERIATRIC POPULATION
  • 4.4.2 TECHNOLOGICAL ADVANCEMENTS IN DEVICE DESIGN

5 MARKET FACTOR ANALYSIS

• 5.1 PORTER'S FIVE FORCES MODEL
  • 5.1.1 THREAT OF NEW ENTRANTS
  • 5.1.2 BARGAINING POWER OF SUPPLIERS
  • 5.1.3 THREAT OF SUBSTITUTES
  • 5.1.4 BARGAINING POWER OF BUYERS
  • 5.1.5 INTENSITY OF RIVALRY
• 5.2 IMPACT OF COVID-19 ON THE GLOBAL FOOT AND ANKLE DEVICE MARKET

6 GLOBAL FOOT AND ANKLE DEVICE MARKET, BY DEVICE TYPE

• 6.1 OVERVIEW
• 6.2 ORTHOPEDIC IMPLANTS AND DEVICES
  • 6.2.1 FIXATION DEVICES
    • 6.2.1.1 INTERNAL FIXATION DEVICES
      • 6.2.1.1.1 SCREWS
      • 6.2.1.1.2 PLATES
      • 6.2.1.1.3 WIRES & PINS
      • 6.2.1.1.4 FUSION NAILS
      • 6.2.1.1.5 STAPLE
    • 6.2.1.2 EXTERNAL FIXATION DEVICES
      • 6.2.1.2.1 UNILATERAL FIXATORS
      • 6.2.1.2.2 RING ANKLE FIXATORS
      • 6.2.1.2.3 HYBRID FIXATORS
  • 6.2.2 JOINT IMPLANTS
    • 6.2.2.1 ANKLE IMPLANTS (ANKLE REPLACEMENT DEVICES)
    • 6.2.2.2 SUBTALAR JOINT IMPLANTS/SUBTALAR JOINT RECONSTRUCTION DEVICES
    • 6.2.2.3 PHALANGEAL IMPLANTS
• 6.3 SOFT-TISSUE MANAGEMENT DEVICES
  • 6.3.1 ARTIFICIAL TENDONS & LIGAMENTS
  • 6.3.2 MUSCULOSKELETAL REINFORCEMENT DEVICES
• 6.4 PROSTHESES
  • 6.4.1 SOLID ANKLE CUSHION HEEL (SACH) FOOT
  • 6.4.2 SINGLE-AXIAL PROSTHESES
  • 6.4.3 MULTIAXIAL PROSTHESES
  • 6.4.4 DYNAMIC RESPONSE/ENERGY-STORING PROSTHESES
  • 6.4.5 MICROPROCESSOR-CONTROLLED (MPC) PROSTHESES
• 6.5 BRACING AND SUPPORT DEVICES

7 GLOBAL FOOT AND ANKLE DEVICE MARKET, BY APPLICATION

• 7.1 OVERVIEW
• 7.2 TRAUMA
• 7.3 DIABETES
• 7.4 NEUROLOGICAL DISORDERS
• 7.5 MIDFOOT ARTHRODESIS
• 7.6 DEFORMITY CORRECTION
• 7.7 OTHERS

8 GLOBAL FOOT AND ANKLE DEVICE MARKET, BY END USER

• 8.1 OVERVIEW
• 8.2 HOSPITALS & CLINICS
• 8.3 PHYSIOTHERAPY CENTERS
• 8.4 ACADEMIC & RESEARCH ORGANIZATIONS

9 GLOBAL FOOT AND ANKLE DEVICE MARKET, BY REGION

• 9.1 OVERVIEW
• 9.2 NORTH AMERICA
  • 9.2.1 US
  • 9.2.2 CANADA
• 9.3 EUROPE
  • 9.3.1 GERMANY
  • 9.3.2 FRANCE
  • 9.3.3 UK
  • 9.3.4 ITALY
  • 9.3.5 SPAIN
  • 9.3.6 RUSSIA
  • 9.3.7 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 CHINA
  • 9.4.2 INDIA
  • 9.4.3 JAPAN
  • 9.4.4 SOUTH KOREA
  • 9.4.5 MALAYSIA
  • 9.4.6 THAILAND
  • 9.4.7 INDONESIA
  • 9.4.8 REST OF ASIA PACIFIC
• 9.5 SOUTH AMERICA
  • 9.5.1 BRAZIL
  • 9.5.2 MEXICO
  • 9.5.3 ARGENTINA
  • 9.5.4 REST OF SOUTH AMERICA
• 9.6 MIDDLE EAST AND AFRICA
  • 9.6.1 GCC COUNTRIES
  • 9.6.2 SOUTH AFRICA
  • 9.6.3 REST OF MEA

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 MARKET SHARE ANALYSIS, 2024
• 10.3 COMPETITOR DASHBOARD
• 10.4 PUBLIC PLAYERS STOCK SUMMARY
• 10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL
• 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 10.6.1 PRODUCT LAUNCH
  • 10.6.2 PRODUCT APPROVAL
  • 10.6.3 PRODUCT EXPANSION
  • 10.6.4 ACQUISITION
  • 10.6.5 PARTNERSHIP

11 COMPANY PROFILES

• 11.1 ORTHOFIX MEDICAL INC
  • 11.1.1 COMPANY OVERVIEW
  • 11.1.2 FINANCIAL OVERVIEW
  • 11.1.3 PRODUCTS OFFERED
  • 11.1.4 KEY DEVELOPMENTS
  • 11.1.5 SWOT ANALYSIS
  • 11.1.6 KEY STRATEGIES
• 11.2 ARTHREX, INC.
  • 11.2.1 COMPANY OVERVIEW
  • 11.2.2 FINANCIAL OVERVIEW
  • 11.2.3 PRODUCTS OFFERED
  • 11.2.4 KEY DEVELOPMENTS
  • 11.2.5 KEY STRATEGIES
• 11.3 INVIBIO LTD.
  • 11.3.1 COMPANY OVERVIEW
  • 11.3.2 FINANCIAL OVERVIEW
  • 11.3.3 PRODUCT OFFERED
  • 11.3.4 KEY DEVELOPMENTS
  • 11.3.5 SWOT ANALYSIS
  • 11.3.6 KEY STRATEGIES
• 11.4 STRYKER
  • 11.4.1 COMPANY OVERVIEW
  • 11.4.2 FINANCIAL OVERVIEW
  • 11.4.3 PRODUCTS OFFERED
  • 11.4.4 KEY DEVELOPMENTS
  • 11.4.5 SWOT ANALYSIS
  • 11.4.6 KEY STRATEGIES
• 11.5 SMITH+NEPHEW
  • 11.5.1 COMPANY OVERVIEW
  • 11.5.2 FINANCIAL OVERVIEW
  • 11.5.3 PRODUCTS OFFERED
  • 11.5.4 KEY DEVELOPMENTS
  • 11.5.5 SWOT ANALYSIS
  • 11.5.6 KEY STRATEGIES
• 11.6 GLOBUS MEDICAL, INC
  • 11.6.1 COMPANY OVERVIEW
  • 11.6.2 FINANCIAL OVERVIEW
  • 11.6.3 PRODUCTS OFFERED
  • 11.6.4 KEY DEVELOPMENTS
  • 11.6.5 KEY STRATEGIES
• 11.7 CONMED CORPORATION
  • 11.7.1 COMPANY OVERVIEW
  • 11.7.2 FINANCIAL OVERVIEW
  • 11.7.3 PRODUCTS OFFERED
  • 11.7.4 KEY DEVELOPMENTS
  • 11.7.5 KEY STRATEGIES
• 11.8 JOHNSON & JOHNSON SERVICES, INC
  • 11.8.1 COMPANY OVERVIEW
  • 11.8.2 FINANCIAL OVERVIEW
  • 11.8.3 PRODUCTS OFFERED
  • 11.8.4 KEY DEVELOPMENTS
  • 11.8.5 SWOT ANALYSIS
  • 11.8.6 KEY STRATEGIES
• 11.9 ZIMMER BIOMET HOLDINGS, INC.
  • 11.9.1 COMPANY OVERVIEW
  • 11.9.2 FINANCIAL OVERVIEW
  • 11.9.3 PRODUCTS OFFERED
  • 11.9.4 KEY DEVELOPMENTS
  • 11.9.5 KEY STRATEGIES
• 11.10 ACUMED LLC
  • 11.10.1 COMPANY OVERVIEW
  • 11.10.2 FINANCIAL OVERVIEW
  • 11.10.3 PRODUCT OFFERED
  • 11.10.4 KEY DEVELOPMENTS
  • 11.10.5 KEY STRATEGIES

12 DATA CITATIONS